Evidence map›Paper›PMID 31940992›Full record

ArticleAntibiotics (Basel, Switzerland)2020

Designed Antimicrobial Peptides for Topical Treatment of Antibiotic Resistant Acne Vulgaris.

Kathryn W Woodburn, Jesse Jaynes, L Edward Clemens

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Eminent Antimicrobial Peptide Resistance inAntibiotics (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Targeting Inflammation in Acne: Current Treatments and Future Prospects.American journal of clinical dermatology · 2023
    Article
  11. Article
  12. Review
  13. Immunomodulatory and Allergenic Properties of Antimicrobial Peptides.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kathryn W WoodburnRiptide Bioscience, Inc., 941 Railroad Avenue, Vallejo, CA 94952, USA.
Jesse JaynesIntegrative Biosciences, College of Agriculture, Environment and Nutritional Sciences, Tuskegee University, Tuskegee, AL 36088, USA.
L Edward ClemensRiptide Bioscience, Inc., 941 Railroad Avenue, Vallejo, CA 94952, USA.
Tuskegee University · US

Funding

Office of Extramural Research, National Institutes of Health 1R43AR073036-01
6 · The paper itself

Abstract

Acne vulgaris, caused by the Gram-positive bacterium

Indexed as

acneantimicrobial peptidesbacterial resistancemultidrug resistancetopical treatment

Identifiers

PMID31940992
PMCPMC7168327
OpenAlexW3000219671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.